Skip to content
SEC filings edition: Friday, November 13, 2026 · 767 companies with filings Publisher's serviceBoardeon, your AI board · Hire your board →
Monday, November 16, 2026Every business day from SEC EDGAR
SEC EDGAR · Nov 13, 2026 1bankruptcies 11delisting notices 12late filings 43leadership changes 6IPO filings 199private raises 90earnings releases
Company page · CIK 1919246 · PTHS

Pelthos Therapeutics Inc.

Filing with the SEC SEC-reporting company Durham, NC NYSE
An email when it files something new with the SEC. Your account

What this means

  • Earlier financial statements no longer reliableOn Aug 13, 2026 the company said previously issued financial statements should no longer be relied on (Item 4.02). A restatement usually follows.
  • Change of auditorOn May 21, 2026 the company reported a change of its independent accountant (Item 4.01). The 8-K must say whether there were disagreements with the former auditor.
  • Several leadership changes3 reports of director or officer changes (Item 5.02) in the last 180 days.
  • Net loss in 2025Net loss of $43.3M for the year (2024: −$8M).
  • Private capital raiseOn Nov 19, 2025 the company filed Form D. A Form D is a notice of an exempt offering, not an SEC approval; the figures are the issuer’s own.

What to do next

Guides from the Companies Daily newsroom, picked for what the register shows.

Financials from XBRL

Calendar-year frame20252024
Revenue$16.8M$0
Net income (loss)−$43.3M−$8M
Total assets$130M$1.4M
Total liabilities$91.5M$4.1M
Stockholders’ equity$38.9M−$2.7M
Cash and equivalents$18M$513K

From XBRL data the company filed with the SEC (data.sec.gov frames, US GAAP, US dollars). A frame aligns the fiscal year with the calendar year closest to it; this company’s fiscal year ends December 31. Check the annual report for the exact figures and periods.

Name as filed
Pelthos Therapeutics Inc.
Formerly: Channel Therapeutics Corp
CIK
0001919246
Tickers
PTHS
Kind of filer
SEC-reporting company
Emerging growth company
Status
Filing with the SEC
State of incorporation
Nevada
Business address
Durham, North Carolina
Industry (SIC)
2836 · Biological products, (no diagnostic substances)
Industry: D · Manufacturing →
Fiscal year ends
December 31
Last annual report
10-K for the period ended Dec 31, 2025
Last quarterly report
10-Q for the quarter ended Sep 30, 2026
Bankruptcy reported
Not in our data
Last edition event
Nov 12, 2026

Filing history

Newest first: the filings we classify (8-K items, late filing notices, delistings, deregistration, IPO registrations, Schedule 13D, Form D, annual and quarterly reports), from Jan 1, 2023. All documents, including those we do not classify, are in the EDGAR filing index.

  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2026
    Form 10-Q · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Results announced
    Form 8-K · items 2.02, 9.01 · filed Nov 12, 2026 · filing · edition of Nov 12, 2026
  • Directors or officers changed
    Form 8-K · items 1.01, 2.03, 3.02, 3.03, 5.02, 5.03, 5.07, 7.01, 9.01 · filed Oct 30, 2026 · filing
  • Director or officer change: Director change
    Form 8-K · items 5.02, 5.07, 9.01 · filed Oct 1, 2026 · filing
  • Earlier financial statements no longer reliable
    Form 8-K · items 4.02 · filed Aug 13, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 13, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2026
    Form 10-Q · filed Aug 13, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 4.01, 5.02, 9.01 · filed May 21, 2026 · filing
  • Change of auditor
    Form 8-K · items 4.01, 5.02, 9.01 · filed May 21, 2026 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2026
    Form 10-Q · filed May 14, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed May 14, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01, 9.01 · filed Apr 10, 2026 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2025
    Form 10-K · filed Mar 19, 2026 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Mar 19, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 7.01 · filed Jan 12, 2026 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed Dec 23, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Nov 19, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2025
    Form 10-Q · filed Nov 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Nov 13, 2025 · filing
  • Results announced
    Form 8-K · items 2.02, 7.01, 9.01 · filed Aug 18, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2025
    Form 10-Q · filed Aug 13, 2025 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Jul 10, 2025 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SCHEDULE 13D · filed Jul 3, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.01, 2.03, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed Jul 2, 2025 · filing
  • Change in control
    Form 8-K · items 1.01, 2.01, 2.03, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed Jul 2, 2025 · filing
  • Acquisition or disposal completed
    Form 8-K · items 1.01, 2.01, 2.03, 3.02, 3.03, 5.01, 5.02, 5.03, 8.01, 9.01 · filed Jul 2, 2025 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2025
    Form 10-Q · filed May 13, 2025 · filing
  • Change of auditor
    Form 8-K · items 1.01, 3.02, 4.01, 5.07, 7.01, 8.01, 9.01 · filed Apr 17, 2025 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2024
    Form 10-K · filed Mar 27, 2025 · filing
  • Directors or officers changed
    Form 8-K · items 1.01, 2.03, 3.03, 5.02, 5.03, 9.01 · filed Nov 18, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Sep 30, 2024
    Form 10-Q · filed Nov 13, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Jun 30, 2024
    Form 10-Q · filed Aug 13, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Aug 6, 2024 · filing
  • Private raise (Form D)
    Form D · items 06b · filed Aug 6, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jul 29, 2024 · filing
  • Quarterly report filed: 10-Q for the quarter ended Mar 31, 2024
    Form 10-Q · filed May 15, 2024 · filing
  • Annual report (10-K): 10-K for the period ended Dec 31, 2023
    Form 10-K · filed Apr 16, 2024 · filing
  • Late annual report notice: Annual report (10-K) will be late
    Form NT 10-K · filed Apr 1, 2024 · filing
  • Directors or officers changed
    Form 8-K · items 5.02, 8.01, 9.01 · filed Mar 18, 2024 · filing
  • Stake of 5% or more with intent to influence: Schedule 13D: stake of 5% or more
    Form SC 13D · filed Feb 26, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Feb 20, 2024 · filing
  • IPO prospectus (424B4): Final prospectus (424B4)
    Form 424B4 · filed Feb 20, 2024 · filing
  • IPO registration filed: Registration statement (S-1)
    Form S-1 · filed Jan 11, 2023 · filing